Fourfold Functionalized Calixarenes
TABLE 3. Summary of the Reactions Involving the Fourfold
Replacement of the Bromine Atoms
conducted as described for 2b using 0.31 g of 1b (0.43 mmol), 1.1
g of NBS (6.2 mmol) and 30 mL of CCl4. Recrystallization from
hexane afforded 0.11 g (22%) of 4, mp 245 °C (dec).
calixarene
nucleophilic reagent
solvent
TFE
TFE
TFE
TFE
TFE
TFE
TFE or HFIP
TFE or HFIP
HFIP
acetic acid
HFIP
product
6e
6a
6b
1H NMR (400 MHz, CDCl3) δ 8.21 (d, J ) 2.2 Hz, 4H), 7.87
2b
2b
2b
2b
2b
2b
2b
2b
2b
2b
2a
2a
TFE
MeOH
EtOH
n-PrOH
i-PrOH
2-methylfuran
NaN3
(d, J ) 2.2 Hz, 4H), 6.29 (s, 2H), 3.33 (s, 12H), 1.38 (s, 36H). 13
C
NMR (100 MHz, CDCl3) δ 149.7, 145.7, 137.6, 134.3, 128.4, 127.6,
66.9, 60.3, 41.2, 34.8, 31.4. MALDI MS, m/z 1098.9 (M - Br).
General Procedure for the Reaction of 2b with Alcohols. A
solution of 2b (0.10 g, 0.10 mmol) in a mixture of 10 mL of TFE
and 10 mL of of the appropriate alcohol (5 mL in the case of
MeOH) was refluxed for 1-2 h (until the solution is clear). The
solvent was evaporated and the residue recrystallized from CHCl3/
MeOH or CHCl3/acetonitrile.
6c
6d
11 (12)a
6g
KSCN
10
6f
ethylene glycol
acetic acid
m-xylene
2-methylfuran
8 (9)b
13 (14)c
6 (in ref 12)
5,11,17,23-Tetra-tert-butyl-2,8,14,20,25,26,27,28-octameth-
oxycalix[4]arene (6a). The rccc, rcct and rctt forms were not
TFE
a Diels-Alder reaction of the product 11 with benzyne followed by
deoxygenation with Me3SiCl/NaI yielded 12. b LiAlH4 reduction of the
product 8 afforded the tetraalcohol 9. c Methylation of the product 13
afforded 14.
1
separated. The signals in the H NMR spectrum were assigned to
the different isomers on the basis of their symmetry pattern.
rccc form: 1H NMR (400 MHz, CDCl3) δ 7.05 (s, 8H), 5.78 (s,
4H), 3.92 (s, 12H), 3.49 (s, 12H), 1.08 (s, 36H). rcct form: 1H
NMR (400 MHz, CDCl3) δ 7.79 (d, J ) 2.4 Hz, 1H), 7.44 (d, J )
2.4 Hz, 1H), 7.42 (d, J ) 2.4 Hz, 1H), 7.36 (d, J ) 2.4 Hz, 1H),
7.29 (d, J ) 2.4 Hz, 1H), 7.01 (d, J ) 2.4 Hz, 1H), 6.92 (d, J )
2.4 Hz, 1H), 6.75 (d, J ) 2.4 Hz, 1H), 5.53 (s, 1H), 5.49 (s, 1H),
5.13 (s, 1H), 5.01 (s, 1H), 3.75 (s, 3H), 3.67 (s, 3H), 3.63 (s, 3H),
3.55 (s, 3H), 3.45 (s, 3H), 3.40 (s, 3H), 3.37 (s, 3H), 2.91 (s, 3H),
1.31 (s, 9H), 1.16 (s, 9H), 1.09 (s, 9H), 1.07 (s, 9H). rctt form:
1H NMR (400 MHz, CDCl3) δ 7.69 (s, 2H), 7.17 (d, J ) 2.4 Hz,
2H), 7.15 (s, 2H), 7.12 (d, J ) 2.4 Hz, 2H), 5.61 (s, 2H), 5.09 (s,
2H), 3.62 (s, 3H), 3.45 (s, 6H), 3.44 (s, 3H), 3.43 (s, 6H), 3.42 (s,
3H), 3.41 (s, 3H), 1.44 (s, 18H), 1.17 (s, 18H). MALDI MS, m/z
863.36 (M + K)+.
isoclinal(I)-isoclinal(II) and diequatorial-diisoclinal(II) dis-
positions of substituents, respectively. Apparently, conforma-
tions avoiding axial dispositions of substituents are favored.
Conclusions
The tetrabromo derivatives readily react with alcohol nu-
cleophiles, azide, thiocyanate, acetoxy and aromatic compounds
under solvolytic conditions, to afford calixarenes which are
functionalized fourfold at the bridges (Table 3). In most cases
examined, the reaction proceeds with high stereoselectivity,
yielding the rccc product. The tetramethoxy derivative 6a is
configurationally labile in CHCl3/MeOH solutions. The 2-me-
thylfuranyl substituents at the bridges can be further function-
alized.
5,11,17,23-Tetra-tert-butyl-25,26,27,28-tetramethoxy-2,8,14,-
1
20-tetrapropoxycalix[4]arene (rccc form) (6c): H NMR (400
MHz, CDCl3) δ 7.09 (s, 8H), 5.87 (s, 4H), 3.90 (s, 12H), 3.53 (t,
J ) 6.8 Hz, 8H), 1.71 (m, 8H), 1.08 (s, 36H), 1.00 (t, J ) 7.4 Hz,
12H). 13C NMR (100 MHz, CDCl3) δ 153.4, 145.4, 134.4, 122.1,
72.5, 70.9, 61.4, 34.2, 31.3, 23.3, 11.0. Mp 220-225 °C. MALDI
MS, m/z 959.54 (M + Na)+.
5,11,17,23-Tetra-tert-butyl-2,8,14,20-tetraisopropoxy-25,26,-
27,28-tetramethoxycalix[4]arene (rccc form) (6d): 1H NMR (400
MHz, CDCl3) δ 7.09 (s, 8H), 6.09 (s, 4H), 3.92 (s, 12H), 3.79 (h,
J ) 6.1 Hz, 4H), 1.28 (d, J ) 6.1 Hz, 24H), 1.08 (s, 36H). 13C
NMR (100 MHz, CDCl3) δ 153.3, 145.3, 134.6, 122.4, 69.3, 68.5,
61.5, 34.2, 31.3, 22.3. Mp 220-225 °C. MALDI MS, m/z 959.56
(M + Na)+.
Experimental Section
2,8,14,20-Tetrabromo-25,26,27,28-tetramethoxycalix[4]-
arene (rccc form) (2a). A mixture of 1a38 (8.0 g, 16.7 mmol),
NBS (13.3 g, 74.7 mmol) and CCl4 (300 mL) was refluxed while
irradiated with a spotlight (100 W). After 4 h, a second portion of
NBS (7.2 g, 40.5 mmol) was added. Reflux was continued for an
additional 18 h. After cooling, the solvent was washed once with
aq Na2SO3 and twice with water. The organic phase was dried
(MgSO4) and evaporated to yield 5.0 g (38%) of 2a. The crude
material is usually pure enough to be used in subsequent reactions.
If needed, recrystallization can be conducted from acetone or
CHCl3/MeOH, mp 260-265 °C (lit8 265-270 °C). 1H NMR (400
MHz, CDCl3) δ 7.10 (d, J ) 7.8 Hz, 8H), 6.78 (t, J ) 7.8 Hz,
4H), 6.70 (s, 4H), 3.99 (s, 12H).
2,8,14,20-Tetrabromo-5,11,17,23-tetra-tert-butyl-25,26,27,28-
tetramethoxycalix-[4]arene (rccc form) (2b). A mixture of 1b38
(15.3 g, 21.7 mmol), NBS (15.6 g, 87.6 mmol) and CCl4 (600 mL)
was refluxed for 22 h while irradiated with a spotlight (100 W).
The solvent was washed once with aq Na2SO3 and twice with water.
The organic phase was dried (MgSO4) and evaporated. The crude
product was recrystallized from CHCl3/MeOH to yield 6.0 g (27%)
of 2b, mp 290 °C (dec).
5,11,17,23-Tetra-tert-butyl-2,8,14,20-tetrakis(2′-hydroxyethoxy)-
25,26,27,28-tetramethoxycalix[4]arene (rccc form) (6f). A mix-
ture of 0.1 g of 2b, 10 mL of HFIP and 5 mL of ethylene glycol
was refluxed for 2 h. The solvent was evaporated, and the residue
was dissolved in chloroform. The organic phase was washed twice
with water and then dried and evaporated. After recrystallization
of the residue from CHCl3/MeOH 20 mg (22%) of 6f was obtained,
mp 285-288 °C.
1H NMR (400 MHz, CDCl3) δ 7.07 (s, 8H), 5.94 (s, 4H), 3.92
(s, 12H), 3.84 (m, 8H), 3.73 (m, 8H), 2.10 (t, J ) 5.5 Hz, 4H,
OH), 1.09 (s, 36H). 13C NMR (100 MHz, CDCl3) δ 153.2, 145.9,
134.0, 122.2, 73.3, 70.8, 62.1, 61.7, 34.2, 31.3. MALDI MS, m/z
967.7 (M + Na)+.
2,8,14,20-Tetraacetoxy-5,11,17,23-tetra-tert-butyl-25,26,27,28-
tetramethoxycalix[4]arene (8). A solution of 1.0 g of 2b in 150
mL of acetic acid was refluxed for 18 h. After cooling, the solvent
was evaporated and the residue recrystallized from CHCl3/MeOH
to yield 215 mg of tetraacetoxy 8 (23%), mp 345-348 °C (dec).
1H NMR (400 MHz, CDCl3) δ 7.40 (s, 4H), 7.02 (s, 8H), 3.99
(s, 12H), 2.18 (s, 12H), 1.09 (s, 36H). 13C NMR (100 MHz, CDCl3)
δ 169.9, 152.6, 145.6, 133.1, 122.3, 67.3, 61.9, 34.2, 31.3, 21.3.
MALDI MS, m/z 959.4 (M + Na+).
1H NMR (400 MHz, CDCl3) δ 7.27 (s, 8H), 6.71 (s, 4H), 3.99
(s, 12H), 1.11 (s, 36H). 13C NMR (100 MHz, CDCl3) δ 150.3,
146.6, 134.0, 125.7, 61.3, 44.1 (CBr), 34.4, 31.2. MALDI MS, m/z
1042.99 (M + Na)+, m/z 1058.96 (M + K)+.
2,2,8,14,14,20-Hexabromo-5,11,17,23-tetra-tert-butyl-25,26,-
27,28-tetramethoxycalix[4]arene (cis form) (4). The reaction was
5,11,17,23-Tetra-tert-butyl-2,8,14,20-tetrahydroxy-25,26,27,-
28-tetramethoxycalix[4]arene (9). To an ice-cold solution of 8
(38) Gutsche, C. D.; Dhawan, B.; Levine, J. A.; No, K. H.; Bauer, L. J.
Tetrahedron 1983, 39, 409.
J. Org. Chem, Vol. 73, No. 7, 2008 2605